Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03699930 · ClinicalTrials.gov registry record · NA
Impact of Neuromodulation on Language Impairments in Stroke Patients
A NA study, sponsored by Casa Colina Hospital and Centers for Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT03699930 is a NA study that has completed, run by Casa Colina Hospital and Centers for Healthcare. The registered enrollment target is 24 participants.
The verdict
NCT03699930, a NA study, has completed, sponsored by Casa Colina Hospital and Centers for Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
Up to 40% of stroke survivors suffer from aphasia, making recovery of language abilities a top priority in stroke rehabilitation. Conventional speech and language therapy may have limited effectiveness. Leveraging multimodal data (behavioral, neuroimaging, and genetics), this study aims to 1) evaluate the efficacy of combining tDCS with speech therapy, 2) examine neural changes associated with recovery, 3) identify factors influencing response to treatment.
Interventions
- DEVICE tDCS
- BEHAVIORAL Speech and language therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2018-01-01 |
| Est. Completion | 2023-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03699930
The ClinicalTrials.gov registry entry for NCT03699930 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Casa Colina Hospital and Centers for Healthcare, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which tDCS is the first listed.
NCT03699930 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03699930 about?
NCT03699930 is a clinical study titled "Impact of Neuromodulation on Language Impairments in Stroke Patients". Up to 40% of stroke survivors suffer from aphasia, making recovery of language abilities a top priority in stroke rehabilitation. Conventional speech and language therapy may have limited effectiveness. Leveraging multimodal data (behavioral, neuroimaging, and genetics), this study aims to 1) evalua...
What is the current status of trial NCT03699930?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2018-01-01. Estimated completion is 2023-01-01.
What interventions are being tested in trial NCT03699930?
The interventions under investigation include: tDCS (DEVICE), Speech and language therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT03699930?
This trial is sponsored by Casa Colina Hospital and Centers for Healthcare, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.